Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of SER120 Nasal Spray in Elderly Patients with Nocturia
NCT01259128Phase 3Completed
- Sponsor
- Serenity Pharmaceuticals
- Start
- Apr 2010
- Primary completion
- Nov 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Serenity Pharmaceuticals. Started Apr 2010; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01259128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259128.